StockData
Recursion Pharmaceuticals, Inc. logo

Recursion Pharmaceuticals, Inc. (RXRX) stock

RXRXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 8/302% below fair value
$2.90−0.28 (-8.79%)

Close on Nov 16, 2026Market cap $1.56BP/E –Yield –

Recursion Pharmaceuticals r&d expenses

Research and development expenses are spending on new products and technology.

Recursion Pharmaceuticals's R&D Expenses for the twelve months ending Jun 30, 2026 was $394.51M, down 8.5% year over year. For fiscal 2025 it was $475.27M, up 51.2% from the year before. The highest annual figure on record is $475.27M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$475.27M+51.2%
FY2024Dec 31, 2024$314.42M+30.3%
FY2023Dec 31, 2023$241.23M+54.9%
FY2022Dec 31, 2022$155.70M+15.1%
FY2021Dec 31, 2021$135.27M+113.6%
FY2020Dec 31, 2020$63.32M+38.2%
FY2019Dec 31, 2019$45.81M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$89.61M-30.3%
Q1 FY2026Mar 31, 2026$87.90M-32.2%
Q4 FY2025Dec 31, 2025$95.94M-2.4%
Q3 FY2025Sep 30, 2025$121.06M+62.3%
Q2 FY2025Jun 30, 2025$128.64M+74.0%
Q1 FY2025Mar 31, 2025$129.63M+91.9%
Q4 FY2024Dec 31, 2024$98.33M+41.5%
Q3 FY2024Sep 30, 2024$74.60M+6.6%
Q2 FY2024Jun 30, 2024$73.93M+34.3%
Q1 FY2024Mar 31, 2024$67.56M+44.7%
Q4 FY2023Dec 31, 2023$69.48M+58.0%
Q3 FY2023Sep 30, 2023$70.01M+71.4%
Q2 FY2023Jun 30, 2023$55.06M+43.2%
Q1 FY2023Mar 31, 2023$46.68M+43.9%
Q4 FY2022Dec 31, 2022$43.98M-8.9%
Q3 FY2022Sep 30, 2022$40.84M+22.8%
Q2 FY2022Jun 30, 2022$38.44M+29.8%
Q1 FY2022Mar 31, 2022$32.44M+34.6%
Q4 FY2021Dec 31, 2021$48.29M+133.3%
Q3 FY2021Sep 30, 2021$33.25M+101.1%
Q2 FY2021Jun 30, 2021$29.62M+123.7%
Q1 FY2021Mar 31, 2021$24.11M+87.7%
Q4 FY2020Dec 31, 2020$20.70M–
Q3 FY2020Sep 30, 2020$16.54M–
Q2 FY2020Jun 30, 2020$13.24M–
Q1 FY2020Mar 31, 2020$12.84M–

More Recursion Pharmaceuticals figures

See a number that looks wrong?